food fermentations and probiotic purposes. Due to its robust properties, it is also increasingly 23 considered for use as a cell factory. It produces several industrially important compounds such as 24 1,3-propanediol and reuterin natively, but for cell factory purposes, developing improved strategies 25 for engineering and fermentation optimization is crucial. Genome-scale metabolic models can be 26 highly beneficial in guiding rational metabolic engineering. Reconstructing a reliable and a 27 quantitatively accurate metabolic model requires extensive manual curation and incorporation of 28 experimental data. 29
Results 30
A genome-scale metabolic model of L. reuteri JCM 1112 T was reconstructed and the resulting model, 31
Lreuteri_530, was validated and tested with experimental data. Several knowledge gaps in the 32 metabolism were identified and resolved during this process, including presence/absence of 33 glycolytic genes. Flux distribution between the two glycolytic pathways, the phosphoketolase and 34
Embden-Meyerhof-Parnas pathways, varies considerably between LAB species and strains. As these 35 pathways result in different energy yields, it is important to include strain-specific utilization of these 36 pathways in the model. We determined experimentally that the Embden-Meyerhof-Parnas pathway 37 carried at most 7% of the total glycolytic flux. Predicted growth rates from Lreuteri_530 were in good 38 agreement with experimentally determined values. To further validate the prediction accuracy of 39 Lreuteri_530, the predicted effects of glycerol addition and adhE gene knock-out, which results in 40 impaired ethanol production, were compared to in vivo data. Examination of both growth rates and 41 uptake-and secretion rates of the main metabolites in central metabolism demonstrated that the 42 model was able to accurately predict the experimentally observed effects. Lastly, the potential of L. 43 reuteri as a cell factory was investigated, resulting in a number of general metabolic engineering 44 strategies. 45
Conclusion 46
We have constructed a manually curated genome-scale metabolic model of L. reuteri JCM 1112 T that 47 has been experimentally parameterized and validated and can accurately predict metabolic behavior 48 of this important platform cell factory. 49 1. Introduction 1. Introduction 1. Introduction 1. Introduction 50 Lactobacillus reuteri is a heterofermentative Lactic Acid Bacterium (LAB) that is present in the human 51 gut and is an important probiotic organism (Saulnier et al., 2011) . There is an increasing interest in 52 using it as a cell factory for the production of green chemicals and fuels in a biorefinery (Dishisha, 53 Pereyra, Pyo, Britton, & Hatti-Kaul, 2014; Ricci et al., 2015) , due to its robustness properties. It has 54 high growth and glycolytic rates, without the requirement for either aeration or strictly anaerobic 55 conditions. It is tolerant to low pH, ethanol and salt, and has a wide growth temperature range. 56
Moreover, it is genetically accessible, enabling metabolic engineering for cell factory optimization 57 (Bosma, Forster, & Nielsen, 2017) . The species is known to produce 1,3-propanediol, reuterin, and 58 other related industrially important compounds in high yields from glycerol (Dishisha et al., 2014) , of 59 which reuterin has also since long been known as antimicrobial (Talarico & Dobrogosz, 1989) . L. 60 reuteri also has most of the genes encoding for the enzymes needed for biosynthesis of 1,2-61 propanediol and 1-propanol, both of which are industrially relevant chemicals. These compounds 62 are, however, not produced under normal conditions by L. reuteri, requiring improved engineering-63 and optimization strategies to achieve commercial level cell factories and production processes 64 (International Publication Number WO 2014/102180 AI, 2014). 65
Genome-scale metabolic models are highly useful for directing metabolic engineering strategies, as 66 well as to improve understanding of the physiology and metabolism of the target organism (Rau & 67 Zeidan, 2018; Saulnier et al., 2011) . So far, highly curated and experimentally validated metabolic 68 models have been primarily developed for model organisms such as Escherichia coli and 69
Saccharomyces cerevisiae, but models for several LAB species are also available, including 70
Lactobacillus plantarum (Teusink et al., 2006) , Lactococcus lactis (Oliveira, Nielsen, & Förster, 2005) 71 and Streptococcus thermophilus (Pastink et al., 2009 ). These LAB are homofermentative or 72 facultatively heterofermentative organisms and have significant differences in metabolism compared 73 to strict heterofermenters such as L. reuteri. A metabolic model for the heterofermenter Leuconostoc 74 mesenteroides (Koduru et al., 2017) is available, but as it is distantly related to L. reuteri it is of 75 limited use here. Models for two probiotic strains of L. reuteri have been previously published 76 (Saulnier et al., 2011) . They were automatically reconstructed from the same draft model we started 77 with here (Santos, 2008) . The two previously published L. reuteri models were used along with 78 transcriptomics data to identify qualitative metabolic differences between the two strains as well as 79 to analyze their probiotic properties (Saulnier et al., 2011) . However, these previous models were not 80 manually curated and were not used to quantitatively predict metabolic behavior. The construction 81 of a genome-scale metabolic model that can be reliably used in basic research and cell factory design 82 is a time-consuming process, requiring significant amount of manual curation and availability of 83 strain-specific phenotypic data. At present, models obtained using automated tools or models that 84 do not include experimental data are generally of limited use for quantitative predictions. 85
Here, we set out to reconstruct the metabolic network of L. reuteri JCM 1112, specifically for use in 86 metabolic engineering applications, which requires collection of phenotypic data under several 87 different conditions. We first performed an in-depth analysis of the genome to evaluate conflicting 88 reports about metabolic pathways compared to strain DSM 20016. We then performed experiments 89 to collect phenotypic data for the wild-type strain as well as for an alcohol dehydrogenase (adhE) 90 knockout strain to constrain, validate, and test the model. Table 1 and an overview of the experimental datasets in Table  95 2. 96
De Mann Rosa Sharp (MRS) medium (incl. 20 g/L glucose) was obtained from VWR and prepared 97 according to the manufacturer's instructions. 98
Chemically Defined Medium (CDM) was used as described in (Santos, 2008) / (Teusink et al., 2005) 99 with the following modifications: arginine 5 g/L, tween-80 1 mL/L. Substrates were 111 mM glucose 100 and 20 mM glycerol as indicated. The CDM was filter-sterilized and the final pH after mixing all 101 components was 5.6. 102
All flask cultivations were performed in a stationary incubator at 37°C. A 5 mm inoculation loop of 103 culture was inoculated from -80°C glycerol stocks into 1 mL MRS with or without glycerol in a 1.5 mL 104
Eppendorf tube and grown overnight (16h). Next morning, cultures were washed 3x with sterile 0.9% 105 NaCl, after which OD600 was measured and cells were transferred to 12 mL CDM with or without 106 glycerol in a 15 mL Falcon tube to a starting OD600 of 0.08. After 4h of growth, OD600 was measured and 107 cultures were transferred to a starting OD600 of 0.05 in 100 mL pre-warmed CDM with or without 108 glycerol in a 100 mL Schott flask. Samples for OD600 measurement and HPLC were taken directly after 109 inoculation (t=0h) and at 2, 3, 4, 5, and 6h; cultures were swirled for mixing prior to taking samples. 110
The 6h samples were also used for protein and amino acid determinations. The time points used 111 were all during exponential growth, ensuring a pseudo steady state (Additional file 1). 112
All bioreactor cultivations were performed in batch mode and samples were taken during 113 exponential/pseudo-steady state (Additional file 1). One of the fermentations was performed in CDM 114 at 37°C in 3.0 L bioreactors (BioFlo 115, New Brunswick Scientific/Eppendorf) with a 2.2 L working 115 volume, 50 rpm agitation without gas sparging. The pH was controlled at 5.7±0.1 using 5N NaOH. 116
Pre-cultures were performed similarly as for the flask cultures described above, with the pre-culture 117 in CDM in 100 mL medium in 100 mL flasks, and reactors inoculated to an OD600 of 0.1. The other two 118 reactor cultivations were performed in CDM, with and without glycerol, at 37°C in 0.4 L reactors with 119 a 0.5 L working volume, 50 rpm agitation and sparged with N 2 at 15 mL/min for 1h prior to 120 inoculation. The pH was controlled at 5.8 using 5M NaOH. Fermenters were inoculated to an initial 121 OD600 of 0.05 from an exponentially growing culture on CDM without glycerol. As can be seen in 122
Additional file 1, there is no difference between the cultures in the reactors that were sparged with 123 N2 prior to fermentations and those that were not and hence we decided to treat these as 124
replicates. 125
The correlation factor between cell dry weight (gDW) and OD600 was experimentally determined to be 126 0.4007 gDW/OD600 in CDM and used for calculating gDW from OD600 in all experiments. 127 2.2 Analytical methods 2.2 Analytical methods 2.2 Analytical methods 2.2 Analytical methods 128 Protein concentration of the cells was determined in the 6h samples as described above, via a BCA 129 protein assay (Merck-Millipore cat. 71285) according to the manufacturer's protocol. Prior to the 130 BCA assay, cell pellets were washed once in 0.9% NaCl and resuspended in 0.25 mM Tris-HCl pH 7.5 131 and sonicated on ice with an Ultrasonic Homogenizer 300VT (BioLogics) for 3x 30s at 40% power, 132 with 30s breaks on ice. 133 Amino acid composition of the cells was determined by Ansynth BV (The Netherlands) on washed cell 134 pellets of a 6h CDM culture as described above. 135
Substrates, products and amino acids secreted and taken up during the cultivations were quantified 136 using HPLC. Glucose, glycerol, ethanol, lactate, acetate, citrate, 1,2-propanediol, 1,3-propanediol, 1-137 propanol, 2-propanol, pyruvate, succinate and malate were quantified with either one of two HPLCs: 138 1) a Dionex Ultimate 3000 (Thermo Scientific) containing an LPG-3400SD pump, a WPS-3000 139 autosampler, a UV-visible (UV-Vis) DAD-3000 detector, and an RI-101 refraction index detector. 140
Injection volume was 20 µL. An Aminex HPx87 ion exclusion 125-0140 column was used with a 141 mobile phase of 5 mM H 2 SO 4 , a flow rate of 0.6 mL/min and an oven temperature of 60°C; 2) a 142 Shimadzu LC-20AD equipped with refractive index and UV (210 nm) detectors, with an injection 143 volume of 20 µL. A Shodex SH1011 8.0mmIDx300mm column was used with a mobile phase of 5 mM 144 H 2 SO 4 , a flow rate of 0.6 mL/min and an oven temperature of 50°C. All amino acids, ornithine and 145 GABA were quantified using a Dionex Ultimate 3000 (Thermo Scientific), for which the procedure is 146 as follows: 20 µg/mL 2-aminobutanoic acid and sarcosine were used as internal standards for dilution 147 of the samples; derivatization was performed in the autosampler. 0.5 µL sample was added into 2.5 148 µL of (v/v) 3-mercaptopropionic acid in borate buffer (0.4 M, pH 10.2), mixed and incubated for 20 s 149 at 4°C to reduce free cystines. Then 1 µL of 120 mM iodoacetic acid in 140 mM NaOH was added, 150 mixed and incubated for 20 s at 4°C to alkylate reduced cysteines. 1.5 µL of OPA reagent (10 mg o-151 pthalaldehyde/mL in 3-mercaptopropionic acid) was then added to derivatize primary amino acids. 152
The reaction was mixed and incubated for 20s at 4°C. 1 µL of FMOC reagent (2.5 mg 9-153 fluorenylmethyl chloroformate/mL in acetonitrile) was added, mixed and incubated for 20 s at 4°C to 154 derivatize other amino acids. 50 µL of Buffer A (Buffer A: 40 mM Na 2 HPO 4 , 0.02% NaN 3 (w/v) at pH 155 7.8) at pH 7 was added to lower the pH of the reaction prior to injecting the 56.5 µL reaction onto a The L. reuteri JCM 1112 metabolic reconstruction was based on an unpublished, automatically 185 generated draft reconstruction of JCM 1112 (Santos, 2008) . We performed extensive manual 186 curation, including: gap filling, updating and adding gene-protein-reaction (GPR) associations, 187 updating gene IDs, updating metabolite-and reaction abbreviations, in line with the BiGG database 188 (King et al., 2016) , updating and adding missing formulas and/or charges to metabolites, fixing 189 unbalanced reactions, adding annotation to metabolites, reactions and genes and detailed review 190 and integration of organism specific data. A biomass objective function was formulated based on 191 available data on L. reuteri and related strains. The ATP cost of growth-associated maintenance 192 (GAM) was estimated using one of the data sets (Table 2) To predict growth rates the model was constrained with uptake rates of glucose, glycerol and five 218 amino acids (Arg, Ser, Asn, Asp and Glu), and with the secretion rates of ethanol, lactate, acetate and 219 1,3-propanediol. Effects of knocking out the adhE gene were predicted by temporarily deleting it 220 from the network. Where the effects of an active 1,2-propanediol pathway were predicted, a 221 methylglyoxal synthase (MGS) was added to the model and optimized for growth. 222
To predict the theoretical maximum yields of selected target compounds, a reaction enabling the 223 secretion of the corresponding metabolite was added to the model, unless an exchange reaction 224 already existed, and flux through the reaction maximized. The glucose uptake rate was 25. and optimization, we built upon a draft metabolic model of L. reuteri JCM 1112 described in (Santos, 238 2008) that we in turn extensively curated. The Memote tool (Lieven et al., 2018 ) was used to assess 239 the quality of the reconstruction and to guide the curation process (Additional file 5). The main 240 characteristics of the resulting Lreuteri_530 model (Additional file 6) are listed in Table 3 . As the first island consists of glycolytic genes, the implications of its presence or absence are 263 profound. This island is absent in DSM 20016, but we could identify homologs of all this island's 264 genes except glyceraldehyde-3-P dehydrogenase elsewhere in its genome based on annotation 265 and/or BLAST. 266
During the preparation of our model, it became clear that there are inconsistencies in naming and 267 hence gene content of the L. reuteri type strain. We sequenced the DSM 20016 strain that we 268 obtained from DSMZ and this showed that its genome is identical to that of JCM 1112 instead. A 269 similar result of these strains being 'swapped' was obtained by others based on whole genome 270 sequencing (US 2015O125959A1, 2015) and PCR of part of the largest missing region in DSM 20016 271 (Etzold et al., 2014) . This inconsistency between the two strains does not seem to be commonly 272 known and taken into account, and we suspect that some papers referring to either the DSM or the 273 JCM strain might in fact be working with the other strain. and was used to define the corresponding flux split ratio in the model (section 2.5). 330
Sugar transport 331
Transport of carbohydrates can be mediated by ATP-Binding Cassette (ABC) transporters, 332 phosphotransferase systems (PTS), or secondary transporters (permeases of the Major Facilitator 333 Superfamily, MFS) (Saier, 2000) . PTS systems mediate hexose mono-or dimer transport and 334 phosphorylation simultaneously -mostly by using PEP to pyruvate conversion as phosphate donor, 335
whereas ABC-transporters (mostly used for pentoses) and permeases (both pentoses and hexoses) 336 perform only transport, and a separate ATP-utilizing kinase step is needed for sugar phosphorylation. 2008). Furthermore, the L. reuteri glycerol dehydrogenase also has activity as 1,3-PDO:NAD-368 oxidoreductase, whereas in for example Klebsiella pneumoniae, which does produce glycolytic end 369 products from glycerol, these are two different enzymes (Talarico et al., 1990) . It seems that the 370 physiological role of this enzyme in L. reuteri is the reduction of 3-HPA to 1,3-PDO, rather than 371 glycerol to DHA conversion, explaining the lack of growth on glycerol (Talarico et al., 1990) . 372
Other pathways 373
Most heterofermentative LAB possess a malolactic enzyme but no malic enzymes (Landete, Ferrer, 374 Monedero, & Zúñiga, 2013), which is also the case for our L. reuteri strain, based on sequence L. reuteri can produce vitamin B12, and the structure and biosynthetic genes have been studied 397 (Santos et al., 2007 . The corresponding pathway is present in the reconstruction and is active 398 during growth predictions. 399 3.1.2 3.1.2 3.1.2 3.1.2 Biomass Biomass Biomass Biomass reaction and energy requirements reaction and energy requirements reaction and energy requirements reaction and energy requirements 400 A biomass objective function (BOF), which contains all necessary components for biomass 401 biosynthesis, is commonly used to predict growth rate in metabolic models. Ideally, the BOF should 402 be constructed based on organism-specific experimental data, mainly the fractional composition of 403 the macromolecules (proteins, DNA, RNA, lipids, etc.) and their individual building blocks (amino 404 acids, nucleotides, fatty acids, etc.), as well as the energy necessary for their biosynthesis (Feist & 405 Palsson, 2010). The protein fraction is a significant fraction of the biomass and was therefore 406 measured. The remaining macromolecular fractions were derived from L. plantarum (Teusink et al., 407 2006 ) and L. lactis (Oliveira et al., 2005) . The ratio of amino acids in the L. reuteri biomass was also 408 measured. Nucleotide composition was estimated from the genome, which in the case of RNA is not 409 ideal since it assumes equal transcription of all genes. We however preferred to use this 410 approximation instead of using experimental data from another organism. Fatty acid composition of 411 L. reuteri was obtained from literature (Liu, Hou, Zhang, Zeng, & Qiao, 2014), while phospholipid 412 composition was adopted from L. plantarum. The composition of lipoteichoic acid (Walter et al., 413 2007 ) and exopolysaccharides (Ksonzeková et al., 2016) in L . reuteri were obtained from literature. 414
Peptidoglycan composition was adopted from L. plantarum and glycogen was assumed to be 415 negligible Dauner, Storni, & Sauer, 2001) . 416
Energy required for growth-(GAM) and cell maintenance (NGAM) are important parameters in 417 metabolic models, and can be estimated from ATP production rates, which can be calculated from 418 experimental data obtained at different dilution rates (Tempest & Neijssel, 1984) . Unfortunately, this 419 data is not publicly available for L. reuteri. These parameters have been estimated from experimental 420 data for several other LAB, including L. plantarum, and reported in literature (Teusink et al., 2006) . capabilities, and for L. reuteri this includes auxotrophy for several amino acids. This, combined with 429 the fact that macromolecular biosynthesis is already accounted for in the model reactions, supports 430 the claim that adopting energy parameters from L. plantarum can negatively affect model 431 predictions, as we also observed when evaluating this in our model. We decided to use one of our 432 experimental datasets (Table 2) To validate the model, several different datasets (Table 2) with measured uptake-and secretion rates 440 of carbon sources, amino acids and organic byproducts were used to constrain exchange fluxes in the 441 model. The predicted growth rates were compared with observed experimental growth rates (Figure  442 3). In all cases, flux through the EMPP was set to maximally 7% based on the experimentally 443 determined value (Figure 1) . The chemically defined culture medium used in the growth experiments 444 contained all 20 amino acids, except for L-glutamine. Subsequently, all these amino acids were 445 quantified during growth and the model was constrained with the resulting uptake rates. Of all the 446 amino acids, only arginine was depleted at the end of the exponential phases in data sets A, B and C 447 (Additional file 1). Due to auxotrophy for several amino acids (Glu, His, Thr, Arg, Tyr, Val, Met, Try, 448 Phe, Leu), the model is highly sensitive to uncertainties in measurements, as well as in determined 449 protein-and amino acid fractions of the biomass reaction. To accurately represent amino acids in the 450 biomass reaction, both the protein content and the amino acid ratio were measured (Additional file 451 7). By enabling unrestricted uptake of amino acids in the model, we noticed that only 5 amino acids 452 (Arg, Ser, Asn, Asp, Glu) needed to be constrained with measured uptake rates for accurate growth 453 predictions, for both the wild-type and the mutant. This is due to their role in energy-and cofactor 454 metabolism, not only in biomass biosynthesis. Hence, only this minimum number of amino acids was 455 used to constrain the model in the following. The remainder were assumed to be non-limiting by 456 allowing unrestricted uptake. This has twofold advantage. First, it limits the effects of uncertainties in 457 amino acid uptake rate measurements on model predictions, a problem exacerbated by the amino 458 acid auxotrophy. Second, it simplifies future applications of the model by reducing the number of 459 measurements needed. 460
In most cases, model predictions and in vivo data were in good agreement (Figure 3 ). Datasets C and 461 D in Figure 3 show a variant of the WT strain (marked SJ (WT*)), which lacks two restriction 462 modification (RM) systems for easier genetic manipulation (Table 1) . Datasets E and F show a mutant 463 derived of the SJ strain with a clean and in-frame deletion of the adhE gene (bifunctional 464 aldehyde/alcohol dehydrogenase). The model predicts slightly higher growth rates than observed in 465 vivo for the SJ strain (datasets C and D in Figure 3 ) and the mutant strain grown on glucose and 466 glycerol (F in Figure 3) . Unexpectedly, the RM-modifications in the SJ strain seem to slightly alter its 467 behavior on CDM with glucose and glycerol compared to the WT (Additional file 1). For the mutant 468 strain grown on glucose (dataset E in Figure 3) , the model predicts a slightly lower growth rate than 469 observed in vivo, though both show a large decrease in growth, compared to the WT. The most likely 470 explanation for this is that some glucose is being taken up in vivo, even though the measurements 471 did not show this (the likely amount consumed between two samples is within the error of the 472 assay). Secretion of 2.6 mmol gDW -1 h -1 of lactate and 2.7 mmol gDW -1 h -1 of acetate was observed in 473 vivo. The model, however, does not predict lactate and acetate secretion unless some glucose uptake 474 is allowed. If a glucose uptake of 2.6 mmol gDW -1 h -1 is allowed, the growth rate increases from 0.22 475 to 0.34 h -1 , compared to 0.30 h -1 in vivo. Amino acid measurements showed that the mutant in 476 dataset E used L-arginine to a greater extent than the WT, which the model predicts is used to 477 generate energy via the arginine deiminase pathway, resulting in increased growth. To investigate the applicability of the model for cell factory design, it was used to predict the effects 480 of adding glycerol to the glucose-based culture medium, as well as knocking out the adhE gene, 481 which plays a critical role in ethanol production and redox balance (Figure 1) . The datasets used here 482 are the same as in section 3.2.1 (datasets C -F in Figure 3 ). There, the aim was to validate the model 483 by means of comparing predicted growth rates to experimentally determined growth rates. In this 484 section, we look more specifically at predicted flux distributions in central metabolism, both with and 485 without strain-and condition-specific experimentally determined constraints. For this purpose, we 486 studied two cases in order to answer the following questions: (1) If the model is constrained only 487 with experimentally determined glucose-and five amino acid uptake rates from the WT strain grown 488 and in case 1 the allowed glycerol uptake rate was arbitrarily limited to 25 mmol gDW -1 h -1 , when 502 glycerol effects were being predicted. 503
The flux maps in Figure 4 show results for case 1 (dark green bars). The predicted uptake of glucose 504 and glycerol (dark green bars in figure 4b) is higher than observed in-vivo (light orange bars in figure  505 4b), resulting in higher secretion of by-products and a higher growth rate as well. However, the 506 distribution of secreted by-products is very similar. The effect of glycerol can be predicted quite well 507 with the model as ethanol secretion decreases and acetate secretion increases, relative to glucose 508 uptake, and 1,3-propanediol is secreted in large amounts (compared to graphs in Figure 4a ). Several 509 studies have described an increased growth rate in L. reuteri when glycerol is added to a glucose-510 based medium (in flasks and bioreactors), which is to be expected based on inspection of redox 511 balance (Chen et al., 2016; Santos, 2008; Talarico et al., 1990) and this is also what we observed in 512 silico in case 1. However, in vivo we consistently observed a small decrease in growth rate for this 513 strain when glycerol was added (Additional file 1). 514
In line with existing literature reports (Chen et al., 2016) , knocking out the adhE gene has dramatic 515 effects on the metabolism when glucose is the sole carbon source, both in vivo and in silico (Figure  516 4c). This is due to redox imbalance since AdhE no longer recycles the NADH generated in glycolysis. 517
The predictions in case 1 show highly decreased uptake of glucose, yet a small amount of glucose is 518 still taken up, resulting in acetate and lactate production. As discussed in 3.2.1, it is possible that 519 glucose is being taken up in vivo, even though this is not detected by measurements, which is in line 520 with model predictions and would also explain the lower growth rate observed in silico in case 2 521 compared to in vivo. The higher growth rate in vivo compared to in silico in case 1 is due to a much 522 higher arginine uptake than measured in the WT. Also, in line with published studies (Chen et al., 523 2016), addition of glycerol to the adhE mutant increases the growth rate to almost WT levels ( Figure  524 4d). Similarly to the WT predictions, the model in case 1 predicts slightly higher growth rate and 525 uptake rates of glucose and glycerol, resulting in higher secretion of by-products. But as before, the 526 flux distribution is very similar to the one measured in vivo. 527
In all four conditions in figure 4 the in silico predictions in case 2 and the in vivo data are almost 528 identical, with the exception of the few instances described above. In few cases discrepancies can be 529 explained by carbon imbalance in vivo, which is most likely due to measurement 530 uncertainties. Taken together, these results show that the model can be used to accurately predict 531 metabolic behavior, without requiring extensive experimental data. propanediol-and 1-propanol biosynthetic pathways (see section 3.1.1). Here we used the model to 535 predict how mgs gene insertion would affect the metabolism, specifically in the adhE mutant grown 536 on glucose. The mutant grows poorly on glucose due to redox imbalance (section 3.2.2). The 537 synthesis of both 1,2-propanediol and 1-propanol consume NADH and activating these pathways 538 therefore has the potential to restore growth. As in case 1 above, the model was constrained only 539 with experimental uptake rates of glucose and the 5 amino acids from the WT grown on glucose. The 540
adhE gene was knocked out in silico, and we then compared flux predictions with an added mgs 541 ( Figure 5 ) and without it (Figure 4c) . The mgs addition resulted in a highly increased growth rate 542 (0.11 to 0.49 h -1 ) as well as growth-coupled production of 1-propanol (14.7 mmol gDW -1 h -1 ). Given 543 the good agreement between in silico predictions and in vivo measurements in section 3.2.2, the 544 expression of this gene at a sufficiently high level in vivo is expected to result in a relatively fast 545 growing 1-propanol producing cell factory. and, in many species, the central metabolism is only weakly coupled to biomass formation because 550 of their adaptation to nutrient rich environments. As a result, the carbon source is mostly used for 551 energy gain and is converted to fermentation products in high yields. Combined with high tolerance 552
to environmental stress, these properties have led to significant interest in using LAB as cell factories. 553
The heterofermentative nature of L. reuteri and the dominance of the phosphoketolase over the 554
Embden-Meyerhof-Parnas pathway make some target compounds less suitable than others, with 555 lactic acid being an obvious example. On the other hand, these properties can also be used to an 556 advantage as is demonstrated here We used our newly established L. reuteri metabolic model to 557 study the feasibility of this organism to produce some of the compounds that have been the subject 558 of recently published LAB metabolic engineering experiments. These native and non-native 559 compounds include a flavoring compound (acetoin), a food additive (L-alanine), biofuels (1-propanol 560 and ethanol), chemical building blocks (acetaldehyde and 2,3-butanediol) and an environmentally 561 friendly solvent (ethyl lactate). The last compound has recently been produced in an engineered E. 562 coli strain (Lee & Trinh, 2018) and is an interesting target in L. reuteri since it is a condensation 563 product of the two major products of glucose fermentation via the phosphoketolase pathway, lactate 564 and ethanol. 565
The suitability of L. reuteri for producing a particular compound was assessed in terms of the 566 maximum theoretical yield, using a fixed glucose uptake rate (Table 4 ). This gives an overly optimistic 567 estimate of product yields in most cases since it completely ignores variations in enzyme efficiency, 568 compound toxicity, regulation and other issues outside the scope of the model. The maximum flux is 569 still useful to identify products that appear to be ill suited for a particular metabolism as well as 570 products that may be suitable. 571
The predicted flux for acetaldehyde, acetoin and 2,3-butanediol, which are all derived from acetyl-572 CoA, was low, suggesting that the metabolism in the wild type is not well suited for overproducing 573 these compounds. The flux increased significantly upon addition of methylglyoxal synthase, 574 suggesting the importance of the 1-propanol pathway in cofactor balancing (section 3.2.3). Addition 575 of glycerol to the medium served the same purpose and increased the predicted flux in all cases (data 576 not shown), which is in line with glycerol being known and used as an external electron sink in L. 577 reuteri (Dishisha et al., 2014) . For all the compounds except ethanol and 1-propanol, the addition of a 578 fully functional phosphofructokinase was predicted to increase the yields even further (Table 4) . Such 579 a strategy has been shown successful for mannitol production (Papagianni & Legiša, 2014) . 580
Taken together, the model suggests that L. reuteri is better suited for producing compounds derived 581 from pyruvate than compounds derived from acetyl-CoA and that the simultaneous expression of 582 heterologous MGSA and PFK enzymes is a general metabolic engineering strategy for increasing 583 product yields in L. reuteri. 584
Conclusions Conclusions Conclusions Conclusions

585
In this study, we have established a manually curated genome-scale metabolic model of L. reuteri 586 JCM 1112, referred to as Lreuteri_530, and validated it with experimental data. We identified several 587 knowledge gaps in the metabolism of this organism that we resolved with a combination of 588 experimentation and modeling. The distribution of flux between the PKP and EMPP pathways is 589 strain-specific and in line with other studies, we found that the EMPP activity is maximally around 7% 590 of total glycolytic flux during early exponential phase. The predictive accuracy of the model was 591 estimated by comparing predictions with experimental data. Several scenarios were tested both in 592 vivo and in silico, including addition of glycerol to a glucose-based growth medium and the deletion 593 of the adhE gene, which encodes a bifunctional aldehyde/alcohol dehydrogenase. The results 594 showed that the model gives accurate predictions, both with respect to growth rate and uptake-and 595 secretion rates of main metabolites in the central metabolism. This indicates that the model can be 596 useful for predicting metabolic engineering strategies, such as growth-coupled production of 1-597 propanol. Figure 3 ) and model predictions (Figure 4d )
Growth curves and uptake and secretion data can be found in Additional file 1. 
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